Growth Metrics

Phathom Pharmaceuticals (PHAT) Cash from Operations (2022 - 2026)

Phathom Pharmaceuticals (PHAT) has disclosed Cash from Operations for 5 consecutive years, with 15647000.0 as the latest value for Q1 2026.

  • For Q1 2026, Cash from Operations rose 81.58% year-over-year to 15647000.0; the TTM value through Mar 2026 reached 97492000.0, up 65.51%, while the annual FY2025 figure was 166775000.0, 37.48% up from the prior year.
  • Cash from Operations hit 15647000.0 in Q1 2026 for Phathom Pharmaceuticals, down from 5001000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 5001000.0 in Q4 2025 and bottomed at 84930000.0 in Q1 2025.
  • Average Cash from Operations over 5 years is 43135411.76, with a median of 41041000.0 recorded in 2022.
  • Year-over-year, Cash from Operations crashed 218.56% in 2024 and then skyrocketed 92.12% in 2025.
  • Phathom Pharmaceuticals' Cash from Operations stood at 41041000.0 in 2022, then decreased by 6.72% to 43797000.0 in 2023, then plummeted by 44.89% to 63456000.0 in 2024, then surged by 92.12% to 5001000.0 in 2025, then crashed by 212.88% to 15647000.0 in 2026.
  • According to Business Quant data, Cash from Operations over the past three periods came in at 15647000.0, 5001000.0, and 14115000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.